Thalidomide in relapsed/refractory multiple myeloma: pivotal trials conducted outside the United States. [electronic resource]
Producer: 20040816Description: 8-16 p. digitalISSN:- 0037-1963
- Adjuvants, Immunologic -- administration & dosage
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Australia
- Clinical Trials, Phase II as Topic -- statistics & numerical data
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Europe
- Humans
- Multiple Myeloma -- drug therapy
- Risk Factors
- Salvage Therapy
- Survival Analysis
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.